Literature DB >> 9282853

Brain MR in chronic fatigue syndrome.

A Greco1, C Tannock, J Brostoff, D C Costa.   

Abstract

PURPOSE: To determine the prevalence of MR white matter abnormalities in patients with chronic fatigue syndrome (CFS).
METHODS: Brain MR studies of 43 patients (29 women and 14 men, 22 to 78 years old) with a clinical diagnosis of CFS (n = 15), CFS with associated depression (n = 14), and CFS with associated other psychiatric disorders, namely, anxiety and somatization disorder (n = 14), were compared with brain MR studies in 43 age- and sex-matched control subjects.
RESULTS: MR findings were abnormal in 13 (32%) of the patients in the study group (ages 34 to 78 years) and in 12 (28%) of the control subjects (ages 26 to 73 years). One patient with CFS had multiple areas of demyelination in the supratentorial periventricular white matter. Another patient with CFS and associated depression had a single focus of probable demyelination in the supratentorial periventricular white matter. In four patients with CFS (ages 34 to 48 years) MR abnormalities consisted of one or several punctate hyperintense foci in the corona radiata, centrum ovale, and frontal white matter. The remaining seven patients (ages 50 to 78 years) had frontoparietal subcortical white matter foci of high T2 signal. The prevalence of white matter hyperintensities was not different between the patients and the control subjects.
CONCLUSIONS: Our findings suggest that no MR pattern of white matter abnormalities is specific to CFS.

Entities:  

Mesh:

Year:  1997        PMID: 9282853      PMCID: PMC8338019     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  18 in total

Review 1.  Brain imaging.

Authors:  R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 2.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

Review 3.  Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome.

Authors:  L A Bradley; N L McKendree-Smith; G S Alarcón
Journal:  Curr Rev Pain       Date:  2000

4.  Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study.

Authors:  B K Puri; P M Jakeman; M Agour; K D R Gunatilake; K A C Fernando; A I Gurusinghe; I H Treasaden; A D Waldman; P Gishen
Journal:  Br J Radiol       Date:  2011-11-29       Impact factor: 3.039

Review 5.  Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review.

Authors:  Michael Browning; Paul Fletcher; Michael Sharpe
Journal:  Psychosom Med       Date:  2011-01-07       Impact factor: 4.312

6.  A systematic review of chronic fatigue syndrome: don't assume it's depression.

Authors:  James P Griffith; Fahd A Zarrouf
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

Authors:  David Benjamin Fischer; Arsani Hany William; Adam Campbell Strauss; Elizabeth R Unger; Leonard Jason; Gailen D Marshall; Jordan D Dimitrakoff
Journal:  Fatigue       Date:  2014-06-01

8.  Physiological and neurophysiological determinants of postcancer fatigue: design of a randomized controlled trial.

Authors:  Hetty Prinsen; Gijs Bleijenberg; Machiel J Zwarts; Maria T E Hopman; Arend Heerschap; Hanneke W M van Laarhoven
Journal:  BMC Cancer       Date:  2012-06-18       Impact factor: 4.430

9.  Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome.

Authors:  Tomohisa Okada; Masaaki Tanaka; Hirohiko Kuratsune; Yasuyoshi Watanabe; Norihiro Sadato
Journal:  BMC Neurol       Date:  2004-10-04       Impact factor: 2.474

10.  Brain dysfunction as one cause of CFS symptoms including difficulty with attention and concentration.

Authors:  Benjamin H Natelson
Journal:  Front Physiol       Date:  2013-05-20       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.